Anika Therapeutics Inc (ANIK) is a publicly traded Healthcare sector company. As of July 15, 2026, ANIK trades at $15.57 with a market cap of $209.83M and a P/E ratio of -20.57. ANIK moved -0.86% today. Year to date, ANIK is +61.50%; over the trailing twelve months it is +34.61%. Its 52-week range spans $7.87 to $18.37. Analyst consensus is buy with an average price target of $17.00. Rallies surfaces ANIK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ANIK news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $15.57 |
| Market Cap | $209.83M |
| P/E Ratio | -20.57 |
| EPS | $-0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.37 |
| 52-Week Low | $7.87 |
| Volume | 34.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $112.82M |
| Net Income | $-10.88M |
| Gross Margin | 56.56% |
1 analysts cover ANIK: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.00.